Protalix Biotherapeutics Inc (PLX.TA) Quote| Reuters.com
Edition:
United States

Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

268.30
26 Jun 2016
Change (% chg)

-19.60₪ (-6.81%)
Prev Close
287.90₪
Open
276.10₪
Day's High
277.40₪
Day's Low
267.40₪
Volume
89,874
Avg. Vol
66,931
52-wk High
759.00₪
52-wk Low
267.40₪

PLX.TA

Chart for PLX.TA

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.76
Market Cap(Mil.): ₪264.89
Shares Outstanding(Mil.): 99.81
Dividend: --
Yield (%): --

Financials

  PLX.TA Industry Sector
P/E (TTM): -- 38.82 34.11
EPS (TTM): -1.17 -- --
ROI: -47.43 -5.72 14.23
ROE: -- -4.83 15.46

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Pechala's Reports
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Ford Investor Services, Inc.
$12.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.